IDYA
Ideaya Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.71B
P/E Ratio
—
EPS
$-1.28
Beta
0.02
52W High
$39.28
52W Low
$14.45
50-Day MA
$32.77
200-Day MA
$29.53
Dividend Yield
—
Profit Margin
-52.00%
Forward P/E
4.65
PEG Ratio
—
About Ideaya Biosciences Inc
IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected patient populations using molecular diagnostics. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $218.71M |
| Gross Profit (TTM) | $-95.99M |
| EBITDA | $-156.61M |
| Operating Margin | -870.00% |
| Return on Equity | -10.90% |
| Return on Assets | -8.92% |
| Revenue/Share (TTM) | $2.47 |
| Book Value | $11.65 |
| Price-to-Book | 2.81 |
| Price-to-Sales (TTM) | 12.41 |
| EV/Revenue | 10.35 |
| EV/EBITDA | -7.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 55.40% |
| Shares Outstanding | $87.81M |
| Float | $86.96M |
| % Insiders | 2.42% |
| % Institutions | 110.75% |
Analyst Ratings
Consensus ($50.00 target)
3
Strong Buy13
Buy2
HoldData last updated: 4/8/2026